1. Study of Immunogenicity and Protective Efficacy of Live MDCK-derived Pandemic Influenza Vaccine
- Author
-
Larisa Rudenko, Oleg V. Pyankov, Alexander B. Ryzhikov, Irina F Radaeva, Elena A Nechaeva, Natal’ya V Danil’chenko, Olga G. Pyankova, Alexander P. Agafonov, Kiseleva Lv, and Larionova Nv
- Subjects
Influenza outbreak ,Environmental Engineering ,business.industry ,Immunogenicity ,H1N1 influenza ,Pandemic ,Pandemic influenza ,virus diseases ,Live attenuated influenza vaccine ,Public concern ,Medicine ,business ,Virology - Abstract
Background: The threat of pandemic A/H1N1 influenza is still a matter of considerable public concern. Influenza outbreak in 2009 underlined the importance of rapid production of a sufficient vaccine reserve for pandemic and interpandemic periods. One promising way to allay this concern is development of cell culture-derived live attenuated influenza vaccines (LAIV), because this technology makes it possible to produce a considerable amount of vaccine over a short period of time.
- Published
- 2019
- Full Text
- View/download PDF